PARG Inhibitor Collaboration – BioAuxilium and NEOMED

High Throughput Screening Assay for PARG Inhibitors Montreal, September 18th, 2017 – BioAuxilium Research Inc. and the NEOMED Institute announced today the result of a successful collaboration whereby BioAuxilium has developed and validated for NEOMED a custom TR-FRET-based high-throughput screening (HTS) assay suitable for the discovery of poly (ADP-ribose) glycohydrolase (PARG) inhibitors. “We are delighted … Continue reading PARG Inhibitor Collaboration – BioAuxilium and NEOMED